RxDoctor Payments Data

Keith Chamberland

Acute Care · North Providence, RINPI 1285407676

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,236, more than ten times the $50 reported in 2022.

$2,463in general payments, 2019–2025

Across 122 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$404
  • AbbVie$339
  • Lundbeck LLC$337
  • AstraZeneca$318
  • Novo Nordisk$173
  • Lilly USA, LLC$136
  • plus $756 from 16 others

What the payments were for

  • Food & beverage$2,463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,463 in reported general payments places this provider in the 85th percentile of 66 acute care providers in Rhode Island.

See all acute care providers in Rhode Island

Other acute care in North Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →